Effects of antipsychotic drugs on energy metabolism
Schizophrenia (SCZ) is a complex neuropsychiatric disorder associated with altered bioenergetic pathways and mitochondrial dysfunction. Antipsychotic medications, both first and second-generation, are commonly prescribed to manage SCZ symptoms, but their direct impact on mitochondrial function remai...
Saved in:
Published in | European archives of psychiatry and clinical neuroscience Vol. 274; no. 5; pp. 1125 - 1135 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.08.2024
Springer Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Schizophrenia (SCZ) is a complex neuropsychiatric disorder associated with altered bioenergetic pathways and mitochondrial dysfunction. Antipsychotic medications, both first and second-generation, are commonly prescribed to manage SCZ symptoms, but their direct impact on mitochondrial function remains poorly understood. In this study, we investigated the effects of commonly prescribed antipsychotics on bioenergetic pathways in cultured neurons. We examined the impact of risperidone, aripiprazole, amisulpride, and clozapine on gene expression, mitochondrial bioenergetic profile, and targeted metabolomics after 24-h treatment, using RNA-seq, Seahorse XF24 Flux Analyser, and gas chromatography–mass spectrometry (GC–MS), respectively. Risperidone treatment reduced the expression of genes involved in oxidative phosphorylation, the tricarboxylic acid cycle, and glycolysis pathways, and it showed a tendency to decrease basal mitochondrial respiration. Aripiprazole led to dose-dependent reductions in various mitochondrial function parameters without significantly affecting gene expression. Aripiprazole, amisulpride and clozapine treatment showed an effect on the tricarboxylic acid cycle metabolism, leading to more abundant metabolite levels. Antipsychotic drug effects on mitochondrial function in SCZ are multifaceted. While some drugs have greater effects on gene expression, others appear to exert their effects through enzymatic post-translational or allosteric modification of enzymatic activity. Understanding these effects is crucial for optimising treatment strategies for SCZ. Novel therapeutic interventions targeting energy metabolism by post-transcriptional pathways might be more effective as these can more directly and efficiently regulate energy production. |
---|---|
AbstractList | Schizophrenia (SCZ) is a complex neuropsychiatric disorder associated with altered bioenergetic pathways and mitochondrial dysfunction. Antipsychotic medications, both first and second-generation, are commonly prescribed to manage SCZ symptoms, but their direct impact on mitochondrial function remains poorly understood. In this study, we investigated the effects of commonly prescribed antipsychotics on bioenergetic pathways in cultured neurons. We examined the impact of risperidone, aripiprazole, amisulpride, and clozapine on gene expression, mitochondrial bioenergetic profile, and targeted metabolomics after 24-h treatment, using RNA-seq, Seahorse XF24 Flux Analyser, and gas chromatography-mass spectrometry (GC-MS), respectively. Risperidone treatment reduced the expression of genes involved in oxidative phosphorylation, the tricarboxylic acid cycle, and glycolysis pathways, and it showed a tendency to decrease basal mitochondrial respiration. Aripiprazole led to dose-dependent reductions in various mitochondrial function parameters without significantly affecting gene expression. Aripiprazole, amisulpride and clozapine treatment showed an effect on the tricarboxylic acid cycle metabolism, leading to more abundant metabolite levels. Antipsychotic drug effects on mitochondrial function in SCZ are multifaceted. While some drugs have greater effects on gene expression, others appear to exert their effects through enzymatic post-translational or allosteric modification of enzymatic activity. Understanding these effects is crucial for optimising treatment strategies for SCZ. Novel therapeutic interventions targeting energy metabolism by post-transcriptional pathways might be more effective as these can more directly and efficiently regulate energy production. Schizophrenia (SCZ) is a complex neuropsychiatric disorder associated with altered bioenergetic pathways and mitochondrial dysfunction. Antipsychotic medications, both first and second-generation, are commonly prescribed to manage SCZ symptoms, but their direct impact on mitochondrial function remains poorly understood. In this study, we investigated the effects of commonly prescribed antipsychotics on bioenergetic pathways in cultured neurons. We examined the impact of risperidone, aripiprazole, amisulpride, and clozapine on gene expression, mitochondrial bioenergetic profile, and targeted metabolomics after 24-h treatment, using RNA-seq, Seahorse XF24 Flux Analyser, and gas chromatography-mass spectrometry (GC-MS), respectively. Risperidone treatment reduced the expression of genes involved in oxidative phosphorylation, the tricarboxylic acid cycle, and glycolysis pathways, and it showed a tendency to decrease basal mitochondrial respiration. Aripiprazole led to dose-dependent reductions in various mitochondrial function parameters without significantly affecting gene expression. Aripiprazole, amisulpride and clozapine treatment showed an effect on the tricarboxylic acid cycle metabolism, leading to more abundant metabolite levels. Antipsychotic drug effects on mitochondrial function in SCZ are multifaceted. While some drugs have greater effects on gene expression, others appear to exert their effects through enzymatic post-translational or allosteric modification of enzymatic activity. Understanding these effects is crucial for optimising treatment strategies for SCZ. Novel therapeutic interventions targeting energy metabolism by post-transcriptional pathways might be more effective as these can more directly and efficiently regulate energy production.Schizophrenia (SCZ) is a complex neuropsychiatric disorder associated with altered bioenergetic pathways and mitochondrial dysfunction. Antipsychotic medications, both first and second-generation, are commonly prescribed to manage SCZ symptoms, but their direct impact on mitochondrial function remains poorly understood. In this study, we investigated the effects of commonly prescribed antipsychotics on bioenergetic pathways in cultured neurons. We examined the impact of risperidone, aripiprazole, amisulpride, and clozapine on gene expression, mitochondrial bioenergetic profile, and targeted metabolomics after 24-h treatment, using RNA-seq, Seahorse XF24 Flux Analyser, and gas chromatography-mass spectrometry (GC-MS), respectively. Risperidone treatment reduced the expression of genes involved in oxidative phosphorylation, the tricarboxylic acid cycle, and glycolysis pathways, and it showed a tendency to decrease basal mitochondrial respiration. Aripiprazole led to dose-dependent reductions in various mitochondrial function parameters without significantly affecting gene expression. Aripiprazole, amisulpride and clozapine treatment showed an effect on the tricarboxylic acid cycle metabolism, leading to more abundant metabolite levels. Antipsychotic drug effects on mitochondrial function in SCZ are multifaceted. While some drugs have greater effects on gene expression, others appear to exert their effects through enzymatic post-translational or allosteric modification of enzymatic activity. Understanding these effects is crucial for optimising treatment strategies for SCZ. Novel therapeutic interventions targeting energy metabolism by post-transcriptional pathways might be more effective as these can more directly and efficiently regulate energy production. |
Audience | Academic |
Author | Liu, Zoe S. J. Panizzutti, Bruna Connor, Timothy Truong, Trang T. T. Walder, Ken Gray, Laura Spolding, Briana Kowalski, Greg M. McGee, Sean L. Berk, Michael Kidnapillai, Srisaiyini Kim, Jee Hyun Bortolasci, Chiara C. Martin, Sheree D. |
Author_xml | – sequence: 1 givenname: Bruna orcidid: 0000-0002-8825-734X surname: Panizzutti fullname: Panizzutti, Bruna organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation – sequence: 2 givenname: Chiara C. orcidid: 0000-0002-0794-6363 surname: Bortolasci fullname: Bortolasci, Chiara C. organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation – sequence: 3 givenname: Briana surname: Spolding fullname: Spolding, Briana organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation – sequence: 4 givenname: Srisaiyini orcidid: 0000-0001-5313-9813 surname: Kidnapillai fullname: Kidnapillai, Srisaiyini organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation – sequence: 5 givenname: Timothy surname: Connor fullname: Connor, Timothy organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation – sequence: 6 givenname: Sheree D. surname: Martin fullname: Martin, Sheree D. organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation – sequence: 7 givenname: Trang T. T. orcidid: 0000-0001-9301-5911 surname: Truong fullname: Truong, Trang T. T. organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation – sequence: 8 givenname: Zoe S. J. orcidid: 0000-0002-0269-0119 surname: Liu fullname: Liu, Zoe S. J. organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation – sequence: 9 givenname: Laura surname: Gray fullname: Gray, Laura organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation – sequence: 10 givenname: Greg M. orcidid: 0000-0002-1599-017X surname: Kowalski fullname: Kowalski, Greg M. organization: Metabolic Research Unit, School of Medicine, Institute for Physical Activity and Nutrition – sequence: 11 givenname: Sean L. orcidid: 0000-0001-6953-106X surname: McGee fullname: McGee, Sean L. organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation – sequence: 12 givenname: Jee Hyun orcidid: 0000-0002-1299-4300 surname: Kim fullname: Kim, Jee Hyun organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, Florey Institute of Neuroscience and Mental Health – sequence: 13 givenname: Michael orcidid: 0000-0002-5554-6946 surname: Berk fullname: Berk, Michael organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, Barwon Health, University Hospital Geelong, Department of Psychiatry, The University of Melbourne, Orygen, The National Centre for Excellence in Youth Mental Health, Florey Institute of Neuroscience and Mental Health – sequence: 14 givenname: Ken orcidid: 0000-0002-6758-4763 surname: Walder fullname: Walder, Ken email: ken.walder@deakin.edu.au organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38072867$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1rFTEUhoNU7G31D7iQATdupp58TWaWpbQqFNzoOuTzmjKTXJPM4v57c3tbiqWULAKH530TznOGTmKKDqGPGC4wgPhaABgMPRDaAxZE9OQN2mBGaT-yCZ-gDUwMekwpO0VnpdwBAOYE3qFTOoIg4yA2iF5770wtXfKdijXsyt78STWYzuZ128axc9Hl7b5bXFU6zaEs79Fbr-biPjzc5-j3zfWvq-_97c9vP64ub3vDGKk9odxoxhU3ylqPKbaWqUEoZ7SmmBun9ci4BsoI517AZDU2TFGh_cQsdfQcfTn27nL6u7pS5RKKcfOsoktrkWQCMlEx8bGhn5-hd2nNsf1OUhADjHwiwxO1VbOTIfpUszKHUnk5ApBB4IE06uIFqh3rlmCaAh_a_L_Ap4fHV704K3c5LCrv5eOWGzAeAZNTKdl5aUJVNaTYmsMsMciDUHkUKptQeS9UHrrJs-hj-6shegyVBsety0_beCX1D-nIr1o |
CitedBy_id | crossref_primary_10_3390_cells13090762 crossref_primary_10_1080_15622975_2025_2453181 |
Cites_doi | 10.1186/s12888-014-0268-x 10.1093/bioinformatics/btu170 10.1038/mp.2013.67 10.1016/j.biopsych.2008.03.004 10.1016/j.intimp.2019.106093 10.1093/bioinformatics/btp616 10.1001/jamapsychiatry.2013.2287 10.1016/j.pnpbp.2012.10.017 10.1080/15622975.2020.1755450 10.1080/07853890801923753 10.3390/antiox12040975 10.1038/mp.2016.75 10.1038/mp.2014.22 10.3390/ijms23137180 10.1080/15622975.2018.1492734 10.1016/j.biopsych.2005.03.031 10.1016/S0140-6736(17)32130-X 10.3390/ijms22137164 10.1016/j.schres.2019.09.007 10.1016/j.biopsych.2011.01.010 10.1093/hmg/ddi022 10.1016/j.schres.2017.06.046 10.1038/s41598-020-69207-4 10.1016/j.euroneuro.2018.01.004 10.1021/acs.jproteome.1c00504 10.1016/j.molmet.2014.02.001 10.1186/1471-244X-9-57 10.15407/ubj88.04.005 10.1016/j.bbabio.2007.10.006 10.1172/jci.insight.125657 10.1017/S003329172200174X 10.3389/fpsyt.2022.950602 10.1016/j.mito.2020.11.009 10.1038/s41467-019-13668-3 10.3727/096368911X600957 10.1046/j.1471-4159.2002.01263.x 10.1038/s41467-022-31436-8 10.1016/j.neubiorev.2014.11.005 10.1146/annurev-clinpsy-032813-153657 10.1016/j.neulet.2004.09.070 10.1186/s40170-019-0207-x 10.1002/syn.22276 10.1089/omi.2011.0118 10.1111/j.2517-6161.1995.tb02031.x 10.1073/pnas.0506580102 10.1038/sj.mp.4001511 10.1038/s41586-022-04556-w 10.1038/tp.2012.13 10.1007/s12035-021-02498-4 10.1093/bioinformatics/bts635 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany. COPYRIGHT 2024 Springer |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany. – notice: COPYRIGHT 2024 Springer |
DBID | AAYXX CITATION NPM 3V. 7TK 7X7 7XB 88E 88G 8AO 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ K9. M0S M1P M2M PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 |
DOI | 10.1007/s00406-023-01727-2 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central (New) ProQuest One ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Psychology Database (ProQuest) ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Psychology MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1433-8491 |
EndPage | 1135 |
ExternalDocumentID | A800267162 38072867 10_1007_s00406_023_01727_2 |
Genre | Journal Article |
GrantInformation_xml | – fundername: National Health and Medical Research Council grantid: GNT1078928; 1156072; 2017131 funderid: http://dx.doi.org/10.13039/501100000925 – fundername: National Health and Medical Research Council grantid: 1156072 – fundername: National Health and Medical Research Council grantid: GNT1078928 – fundername: National Health and Medical Research Council grantid: 2017131 |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 2.D 203 28- 29G 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 7X7 88E 8AO 8FI 8FJ 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDBF ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABIVO ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACUHS ACZOJ ADBBV ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFFNX AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ AXYYD AZFZN AZQEC B-. B0M BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EAD EAP EBC EBD EBLON EBS EIOEI EJD EMB EMK EMOBN EN4 EPL EPS ESBYG ESX F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ IAO IHE IHR IJ- IKXTQ IMOTQ IPY ITC ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M2M M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P9S PF0 PQQKQ PROAC PSQYO PSYQQ PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC TUS U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z7W Z82 Z87 Z8O Z8Q Z8V Z91 ZMTXR ZOVNA ZXP ~8M ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT NPM ABRTQ 7TK 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c442t-235cb45a5caddf131dd4a67aecbb315cebb845b034255f709db1c4a37bf94d3e3 |
IEDL.DBID | 7X7 |
ISSN | 0940-1334 1433-8491 |
IngestDate | Tue Aug 05 08:49:35 EDT 2025 Sat Aug 16 19:41:52 EDT 2025 Wed Aug 06 19:37:57 EDT 2025 Tue Aug 05 03:50:57 EDT 2025 Wed Feb 19 02:08:01 EST 2025 Tue Jul 01 04:31:22 EDT 2025 Thu Apr 24 22:59:46 EDT 2025 Fri Feb 21 02:40:06 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Antipsychotics Energy metabolism Mitochondria Neuroscience Neurons Mental health Schizophrenia Psychiatry |
Language | English |
License | 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c442t-235cb45a5caddf131dd4a67aecbb315cebb845b034255f709db1c4a37bf94d3e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-5313-9813 0000-0002-0269-0119 0000-0002-1299-4300 0000-0001-9301-5911 0000-0002-1599-017X 0000-0002-6758-4763 0000-0002-5554-6946 0000-0001-6953-106X 0000-0002-8825-734X 0000-0002-0794-6363 |
PMID | 38072867 |
PQID | 3076085926 |
PQPubID | 47319 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_2902937958 proquest_journals_3076085926 gale_infotracmisc_A800267162 gale_infotracacademiconefile_A800267162 pubmed_primary_38072867 crossref_citationtrail_10_1007_s00406_023_01727_2 crossref_primary_10_1007_s00406_023_01727_2 springer_journals_10_1007_s00406_023_01727_2 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-08-01 |
PublicationDateYYYYMMDD | 2024-08-01 |
PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
PublicationTitle | European archives of psychiatry and clinical neuroscience |
PublicationTitleAbbrev | Eur Arch Psychiatry Clin Neurosci |
PublicationTitleAlternate | Eur Arch Psychiatry Clin Neurosci |
PublicationYear | 2024 |
Publisher | Springer Berlin Heidelberg Springer Springer Nature B.V |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer – name: Springer Nature B.V |
References | Benjamini, Hochberg (CR29) 1995; 57 Brenner-Lavie (CR43) 2008; 1777 Bolger, Lohse, Usadel (CR25) 2014; 30 Singh (CR10) 2022; 604 Pandya, Howell, Pillai (CR17) 2013; 46 Mittal (CR47) 2017; 187 Robicsek (CR40) 2013; 18 Shao (CR36) 2008; 40 Babich, Shlykov, Kushnarova, Kosterin (CR45) 2016; 88 Megiorni, Mora, Indovina, Mazzilli (CR20) 2005; 373 Martin, McGee (CR33) 2019; 7 Kidnapillai (CR22) 2018 Ben-Shachar (CR7) 2002; 83 Gonzalez-Liencres (CR14) 2014; 14 Robinson, McCarthy, Smyth (CR27) 2010; 26 Scaini (CR46) 2018; 28 Bar-Yosef (CR49) 2020; 10 Bortolasci (CR18) 2020 Du (CR13) 2014; 71 Martin, Morrison, Konstantopoulos, McGee (CR32) 2014; 3 Meng (CR24) 2019; 4 Brennand (CR41) 2015; 20 Chan, McCarthy, Vawter (CR44) 2020; 217 Ľupták, Fišar, Hroudová (CR51) 2021; 58 Choi (CR15) 2009; 9 Prabakaran (CR34) 2004; 9 Hjelm (CR9) 2015; 1 Mısır, Akay (CR3) 2023 Rajasekaran, Venkatasubramanian, Berk, Debnath (CR6) 2015; 48 Jiang (CR54) 2022; 13 (CR1) 2017; 390 Martínez-Reyes, Chandel (CR52) 2020; 11 Rosenfeld, Brenner-Lavie, Ari, Kavushansky, Ben-Shachar (CR50) 2011; 69 De Simone (CR4) 2023; 12 Roberts (CR8) 2021; 56 Panizzutti (CR19) 2021; 22 Iwamoto, Bundo, Kato (CR38) 2005; 14 Yu, Wang, Han, He (CR30) 2012; 16 Rollins (CR48) 2018; 3 Laursen, Nordentoft, Mortensen (CR2) 2014; 10 Nehme (CR11) 2022; 13 Manatt, Chandra (CR5) 2011; 3 Cui (CR53) 2021; 20 Berk (CR16) 2008; 64 Altar (CR37) 2005; 58 CR28 Martins-de-Souza (CR42) 2012; 2 CR26 Townsend (CR35) 2022 Melbourne (CR23) 2020; 79 Da Silveira Paulsen (CR39) 2012; 21 Devaraju (CR12) 2017; 22 Liu (CR21) 2022; 23 Subramanian (CR31) 2005; 102 C Gonzalez-Liencres (1727_CR14) 2014; 14 D Martins-de-Souza (1727_CR42) 2012; 2 BL Rollins (1727_CR48) 2018; 3 T Bar-Yosef (1727_CR49) 2020; 10 S Kidnapillai (1727_CR22) 2018 A Rajasekaran (1727_CR6) 2015; 48 CD Pandya (1727_CR17) 2013; 46 Y Jiang (1727_CR54) 2022; 13 G Yu (1727_CR30) 2012; 16 S Chan (1727_CR44) 2020; 217 SD Martin (1727_CR33) 2019; 7 CA Altar (1727_CR37) 2005; 58 G Scaini (1727_CR46) 2018; 28 P Devaraju (1727_CR12) 2017; 22 H Brenner-Lavie (1727_CR43) 2008; 1777 L Shao (1727_CR36) 2008; 40 L Townsend (1727_CR35) 2022 G De Simone (1727_CR4) 2023; 12 A Subramanian (1727_CR31) 2005; 102 K Iwamoto (1727_CR38) 2005; 14 E Mısır (1727_CR3) 2023 Y Benjamini (1727_CR29) 1995; 57 GBD 2016 DALYs and HALE Collaborators (1727_CR1) 2017; 390 B Panizzutti (1727_CR19) 2021; 22 LG Babich (1727_CR45) 2016; 88 S Prabakaran (1727_CR34) 2004; 9 M Rosenfeld (1727_CR50) 2011; 69 AM Bolger (1727_CR25) 2014; 30 CC Bortolasci (1727_CR18) 2020 G Cui (1727_CR53) 2021; 20 SD Martin (1727_CR32) 2014; 3 K Mittal (1727_CR47) 2017; 187 M Manatt (1727_CR5) 2011; 3 MD Robinson (1727_CR27) 2010; 26 TM Laursen (1727_CR2) 2014; 10 F Du (1727_CR13) 2014; 71 ZSJ Liu (1727_CR21) 2022; 23 B Da Silveira Paulsen (1727_CR39) 2012; 21 F Megiorni (1727_CR20) 2005; 373 M Ľupták (1727_CR51) 2021; 58 1727_CR26 O Robicsek (1727_CR40) 2013; 18 K Brennand (1727_CR41) 2015; 20 M Berk (1727_CR16) 2008; 64 T Singh (1727_CR10) 2022; 604 R Nehme (1727_CR11) 2022; 13 BE Hjelm (1727_CR9) 2015; 1 D Ben-Shachar (1727_CR7) 2002; 83 1727_CR28 KH Choi (1727_CR15) 2009; 9 JK Melbourne (1727_CR23) 2020; 79 Z Meng (1727_CR24) 2019; 4 RC Roberts (1727_CR8) 2021; 56 I Martínez-Reyes (1727_CR52) 2020; 11 |
References_xml | – volume: 14 start-page: 268 year: 2014 ident: CR14 article-title: Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition publication-title: BMC Psychiatry doi: 10.1186/s12888-014-0268-x – volume: 30 start-page: 2114 year: 2014 end-page: 2120 ident: CR25 article-title: Trimmomatic: a flexible trimmer for Illumina sequence data publication-title: Bioinformatics doi: 10.1093/bioinformatics/btu170 – volume: 18 start-page: 1067 year: 2013 end-page: 1076 ident: CR40 article-title: Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients publication-title: Mol Psychiatry doi: 10.1038/mp.2013.67 – volume: 64 start-page: 361 year: 2008 end-page: 368 ident: CR16 article-title: N-acetyl cysteine as a glutathione precursor for schizophrenia–a double-blind, randomized, placebo-controlled trial publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2008.03.004 – volume: 79 year: 2020 ident: CR23 article-title: Treatment with the antipsychotic risperidone is associated with increased M1-like JAK-STAT1 signature gene expression in PBMCs from participants with psychosis and THP-1 monocytes and macrophages publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2019.106093 – volume: 26 start-page: 139 year: 2010 end-page: 140 ident: CR27 article-title: edgeR: a Bioconductor package for differential expression analysis of digital gene expression data publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp616 – volume: 71 start-page: 19 year: 2014 end-page: 27 ident: CR13 article-title: In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy publication-title: JAMA Psychiat doi: 10.1001/jamapsychiatry.2013.2287 – volume: 46 start-page: 214 year: 2013 end-page: 223 ident: CR17 article-title: Antioxidants as potential therapeutics for neuropsychiatric disorders publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2012.10.017 – year: 2020 ident: CR18 article-title: Effects of psychoactive drugs on cellular bioenergetic pathways publication-title: World J Biol Psychiatry doi: 10.1080/15622975.2020.1755450 – volume: 40 start-page: 281 year: 2008 end-page: 295 ident: CR36 article-title: Mitochondrial involvement in psychiatric disorders publication-title: Ann Med doi: 10.1080/07853890801923753 – volume: 12 start-page: 975 year: 2023 ident: CR4 article-title: Schizophrenia synaptic pathology and antipsychotic treatment in the framework of oxidative and mitochondrial dysfunction: translational highlights for the clinics and treatment publication-title: Antioxidants (Basel) doi: 10.3390/antiox12040975 – volume: 22 start-page: 1313 year: 2017 end-page: 1326 ident: CR12 article-title: Haploinsufficiency of the 22q11.2 microdeletion gene Mrpl40 disrupts short-term synaptic plasticity and working memory through dysregulation of mitochondrial calcium publication-title: Mol Psychiatry doi: 10.1038/mp.2016.75 – volume: 20 start-page: 361 year: 2015 end-page: 368 ident: CR41 article-title: Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia publication-title: Mol Psychiatry doi: 10.1038/mp.2014.22 – volume: 23 start-page: 7180 year: 2022 ident: CR21 article-title: Effects of psychotropic drugs on ribosomal genes and protein synthesis publication-title: Int J Mol Sci doi: 10.3390/ijms23137180 – year: 2018 ident: CR22 article-title: The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder publication-title: World J Biol Psychiatry doi: 10.1080/15622975.2018.1492734 – volume: 58 start-page: 85 year: 2005 end-page: 96 ident: CR37 article-title: Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts publication-title: Biol Psychiat doi: 10.1016/j.biopsych.2005.03.031 – volume: 390 start-page: 1260 year: 2017 end-page: 1344 ident: CR1 article-title: Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 publication-title: Lancet doi: 10.1016/S0140-6736(17)32130-X – volume: 22 start-page: 7164 year: 2021 ident: CR19 article-title: Transcriptional modulation of the hippo signaling pathway by drugs used to treat bipolar disorder and schizophrenia publication-title: Int J Mol Sci doi: 10.3390/ijms22137164 – volume: 217 start-page: 136 year: 2020 end-page: 147 ident: CR44 article-title: Psychiatric drugs impact mitochondrial function in brain and other tissues publication-title: Schizophr Res doi: 10.1016/j.schres.2019.09.007 – volume: 69 start-page: 980 year: 2011 end-page: 988 ident: CR50 article-title: Perturbation in mitochondrial network dynamics and in complex I dependent cellular respiration in schizophrenia publication-title: Biol Psychiat doi: 10.1016/j.biopsych.2011.01.010 – volume: 14 start-page: 241 year: 2005 end-page: 253 ident: CR38 article-title: Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis publication-title: Hum Mol Genet doi: 10.1093/hmg/ddi022 – volume: 187 start-page: 67 year: 2017 end-page: 73 ident: CR47 article-title: A comprehensive analysis of mitochondrial genes variants and their association with antipsychotic-induced weight gain publication-title: Schizophr Res doi: 10.1016/j.schres.2017.06.046 – volume: 10 start-page: 12258 year: 2020 ident: CR49 article-title: Mitochondrial function parameters as a tool for tailored drug treatment of an individual with psychosis: a proof of concept study publication-title: Sci Rep doi: 10.1038/s41598-020-69207-4 – volume: 28 start-page: 369 year: 2018 end-page: 380 ident: CR46 article-title: Second generation antipsychotic-induced mitochondrial alterations: implications for increased risk of metabolic syndrome in patients with schizophrenia publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2018.01.004 – volume: 20 start-page: 5010 year: 2021 end-page: 5023 ident: CR53 article-title: Salivary metabolomics reveals that metabolic alterations precede the onset of schizophrenia publication-title: J Proteome Res doi: 10.1021/acs.jproteome.1c00504 – volume: 3 start-page: 408 year: 2014 end-page: 418 ident: CR32 article-title: Mitochondrial dysfunction has divergent, cell type-dependent effects on insulin action publication-title: Mol Metab doi: 10.1016/j.molmet.2014.02.001 – ident: CR26 – volume: 9 start-page: 57 year: 2009 ident: CR15 article-title: Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects publication-title: BMC Psychiatry doi: 10.1186/1471-244X-9-57 – volume: 88 start-page: 5 year: 2016 end-page: 11 ident: CR45 article-title: Ca -dependent regulation of the Ca concentration in the myometrium mitochondria. I. Trifluoperazine effects on mitochondria membranes polarization and [Ca ] publication-title: Ukr Biochem J doi: 10.15407/ubj88.04.005 – volume: 3 start-page: 157 year: 2018 end-page: 169 ident: CR48 article-title: Mitochondrial complex I deficiency in schizophrenia and bipolar disorder and medication influence publication-title: Mol Neuropsychiatry – volume: 1777 start-page: 173 year: 2008 end-page: 185 ident: CR43 article-title: Dopamine modulates mitochondrial function in viable SH-SY5Y cells possibly via its interaction with complex I: relevance to dopamine pathology in schizophrenia publication-title: Biochim Biophys Acta doi: 10.1016/j.bbabio.2007.10.006 – volume: 4 year: 2019 ident: CR24 article-title: The atypical antipsychotic quetiapine induces hyperlipidemia by activating intestinal PXR signaling publication-title: JCI Insight doi: 10.1172/jci.insight.125657 – year: 2022 ident: CR35 article-title: Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of 18FDG-PET studies in schizophrenia publication-title: Psychol Med doi: 10.1017/S003329172200174X – volume: 3 start-page: 84 issue: 5 year: 2011 end-page: 94 ident: CR5 article-title: The effects of mitochondrial dysfunction in schizophrenia publication-title: J Med Genet Genom – volume: 13 year: 2022 ident: CR54 article-title: Plasma metabolomics of schizophrenia with cognitive impairment: a pilot study publication-title: Front Psychiatry doi: 10.3389/fpsyt.2022.950602 – volume: 56 start-page: 91 year: 2021 end-page: 101 ident: CR8 article-title: Mitochondrial dysfunction in schizophrenia: with a focus on postmortem studies publication-title: Mitochondrion doi: 10.1016/j.mito.2020.11.009 – volume: 11 start-page: 102 year: 2020 ident: CR52 article-title: Mitochondrial TCA cycle metabolites control physiology and disease publication-title: Nat Commun doi: 10.1038/s41467-019-13668-3 – volume: 21 start-page: 1547 year: 2012 end-page: 1559 ident: CR39 article-title: Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient publication-title: Cell Transplant doi: 10.3727/096368911X600957 – volume: 83 start-page: 1241 year: 2002 end-page: 1251 ident: CR7 article-title: Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine publication-title: J Neurochem doi: 10.1046/j.1471-4159.2002.01263.x – volume: 13 start-page: 3690 year: 2022 ident: CR11 article-title: The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia publication-title: Nat Commun doi: 10.1038/s41467-022-31436-8 – volume: 48 start-page: 10 year: 2015 end-page: 21 ident: CR6 article-title: Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2014.11.005 – volume: 10 start-page: 425 year: 2014 end-page: 448 ident: CR2 article-title: Excess early mortality in schizophrenia publication-title: Annu Rev Clin Psychol doi: 10.1146/annurev-clinpsy-032813-153657 – volume: 1 start-page: 201 year: 2015 end-page: 219 ident: CR9 article-title: Evidence of mitochondrial dysfunction within the complex genetic etiology of schizophrenia publication-title: Mol Neuropsychiatry – volume: 373 start-page: 105 year: 2005 end-page: 109 ident: CR20 article-title: Expression of neuronal markers during NTera2/cloneD1 differentiation by cell aggregation method publication-title: Neurosci Lett doi: 10.1016/j.neulet.2004.09.070 – volume: 7 start-page: 12 year: 2019 ident: CR33 article-title: A systematic flux analysis approach to identify metabolic vulnerabilities in human breast cancer cell lines publication-title: Cancer Metab doi: 10.1186/s40170-019-0207-x – year: 2023 ident: CR3 article-title: Synaptic dysfunction in schizophrenia publication-title: Synapse doi: 10.1002/syn.22276 – volume: 16 start-page: 284 year: 2012 end-page: 287 ident: CR30 article-title: clusterProfiler: an R Package for comparing biological themes among gene clusters publication-title: OMICS J Integr Biol doi: 10.1089/omi.2011.0118 – volume: 57 start-page: 289 year: 1995 end-page: 300 ident: CR29 article-title: Controlling the false discovery rate: a practical and powerful approach to multiple testing publication-title: J R Stat Soc Ser B (Methodol) doi: 10.1111/j.2517-6161.1995.tb02031.x – volume: 102 start-page: 15545 year: 2005 end-page: 15550 ident: CR31 article-title: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0506580102 – ident: CR28 – volume: 9 start-page: 684 year: 2004 end-page: 697 ident: CR34 article-title: Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001511 – volume: 604 start-page: 509 year: 2022 end-page: 516 ident: CR10 article-title: Rare coding variants in ten genes confer substantial risk for schizophrenia publication-title: Nature doi: 10.1038/s41586-022-04556-w – volume: 2 year: 2012 ident: CR42 article-title: Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients publication-title: Transl Psychiatry doi: 10.1038/tp.2012.13 – volume: 58 start-page: 5548 year: 2021 end-page: 5563 ident: CR51 article-title: Effect of novel antipsychotics on energy metabolism—in vitro study in pig brain mitochondria publication-title: Mol Neurobiol doi: 10.1007/s12035-021-02498-4 – volume: 46 start-page: 214 year: 2013 ident: 1727_CR17 publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2012.10.017 – volume: 20 start-page: 5010 year: 2021 ident: 1727_CR53 publication-title: J Proteome Res doi: 10.1021/acs.jproteome.1c00504 – volume: 14 start-page: 268 year: 2014 ident: 1727_CR14 publication-title: BMC Psychiatry doi: 10.1186/s12888-014-0268-x – volume: 56 start-page: 91 year: 2021 ident: 1727_CR8 publication-title: Mitochondrion doi: 10.1016/j.mito.2020.11.009 – volume: 12 start-page: 975 year: 2023 ident: 1727_CR4 publication-title: Antioxidants (Basel) doi: 10.3390/antiox12040975 – volume: 10 start-page: 425 year: 2014 ident: 1727_CR2 publication-title: Annu Rev Clin Psychol doi: 10.1146/annurev-clinpsy-032813-153657 – volume: 48 start-page: 10 year: 2015 ident: 1727_CR6 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2014.11.005 – year: 2022 ident: 1727_CR35 publication-title: Psychol Med doi: 10.1017/S003329172200174X – volume: 16 start-page: 284 year: 2012 ident: 1727_CR30 publication-title: OMICS J Integr Biol doi: 10.1089/omi.2011.0118 – volume: 13 year: 2022 ident: 1727_CR54 publication-title: Front Psychiatry doi: 10.3389/fpsyt.2022.950602 – year: 2018 ident: 1727_CR22 publication-title: World J Biol Psychiatry doi: 10.1080/15622975.2018.1492734 – volume: 13 start-page: 3690 year: 2022 ident: 1727_CR11 publication-title: Nat Commun doi: 10.1038/s41467-022-31436-8 – volume: 58 start-page: 5548 year: 2021 ident: 1727_CR51 publication-title: Mol Neurobiol doi: 10.1007/s12035-021-02498-4 – volume: 604 start-page: 509 year: 2022 ident: 1727_CR10 publication-title: Nature doi: 10.1038/s41586-022-04556-w – volume: 69 start-page: 980 year: 2011 ident: 1727_CR50 publication-title: Biol Psychiat doi: 10.1016/j.biopsych.2011.01.010 – volume: 28 start-page: 369 year: 2018 ident: 1727_CR46 publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2018.01.004 – year: 2023 ident: 1727_CR3 publication-title: Synapse doi: 10.1002/syn.22276 – volume: 23 start-page: 7180 year: 2022 ident: 1727_CR21 publication-title: Int J Mol Sci doi: 10.3390/ijms23137180 – volume: 1 start-page: 201 year: 2015 ident: 1727_CR9 publication-title: Mol Neuropsychiatry – volume: 18 start-page: 1067 year: 2013 ident: 1727_CR40 publication-title: Mol Psychiatry doi: 10.1038/mp.2013.67 – volume: 217 start-page: 136 year: 2020 ident: 1727_CR44 publication-title: Schizophr Res doi: 10.1016/j.schres.2019.09.007 – volume: 9 start-page: 684 year: 2004 ident: 1727_CR34 publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001511 – volume: 20 start-page: 361 year: 2015 ident: 1727_CR41 publication-title: Mol Psychiatry doi: 10.1038/mp.2014.22 – volume: 11 start-page: 102 year: 2020 ident: 1727_CR52 publication-title: Nat Commun doi: 10.1038/s41467-019-13668-3 – volume: 40 start-page: 281 year: 2008 ident: 1727_CR36 publication-title: Ann Med doi: 10.1080/07853890801923753 – volume: 1777 start-page: 173 year: 2008 ident: 1727_CR43 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbabio.2007.10.006 – ident: 1727_CR26 doi: 10.1093/bioinformatics/bts635 – volume: 88 start-page: 5 year: 2016 ident: 1727_CR45 publication-title: Ukr Biochem J doi: 10.15407/ubj88.04.005 – volume: 10 start-page: 12258 year: 2020 ident: 1727_CR49 publication-title: Sci Rep doi: 10.1038/s41598-020-69207-4 – volume: 26 start-page: 139 year: 2010 ident: 1727_CR27 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp616 – ident: 1727_CR28 – volume: 373 start-page: 105 year: 2005 ident: 1727_CR20 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2004.09.070 – volume: 71 start-page: 19 year: 2014 ident: 1727_CR13 publication-title: JAMA Psychiat doi: 10.1001/jamapsychiatry.2013.2287 – year: 2020 ident: 1727_CR18 publication-title: World J Biol Psychiatry doi: 10.1080/15622975.2020.1755450 – volume: 4 year: 2019 ident: 1727_CR24 publication-title: JCI Insight doi: 10.1172/jci.insight.125657 – volume: 21 start-page: 1547 year: 2012 ident: 1727_CR39 publication-title: Cell Transplant doi: 10.3727/096368911X600957 – volume: 30 start-page: 2114 year: 2014 ident: 1727_CR25 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btu170 – volume: 187 start-page: 67 year: 2017 ident: 1727_CR47 publication-title: Schizophr Res doi: 10.1016/j.schres.2017.06.046 – volume: 9 start-page: 57 year: 2009 ident: 1727_CR15 publication-title: BMC Psychiatry doi: 10.1186/1471-244X-9-57 – volume: 2 year: 2012 ident: 1727_CR42 publication-title: Transl Psychiatry doi: 10.1038/tp.2012.13 – volume: 58 start-page: 85 year: 2005 ident: 1727_CR37 publication-title: Biol Psychiat doi: 10.1016/j.biopsych.2005.03.031 – volume: 3 start-page: 84 issue: 5 year: 2011 ident: 1727_CR5 publication-title: J Med Genet Genom – volume: 3 start-page: 408 year: 2014 ident: 1727_CR32 publication-title: Mol Metab doi: 10.1016/j.molmet.2014.02.001 – volume: 14 start-page: 241 year: 2005 ident: 1727_CR38 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddi022 – volume: 7 start-page: 12 year: 2019 ident: 1727_CR33 publication-title: Cancer Metab doi: 10.1186/s40170-019-0207-x – volume: 3 start-page: 157 year: 2018 ident: 1727_CR48 publication-title: Mol Neuropsychiatry – volume: 79 year: 2020 ident: 1727_CR23 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2019.106093 – volume: 64 start-page: 361 year: 2008 ident: 1727_CR16 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2008.03.004 – volume: 57 start-page: 289 year: 1995 ident: 1727_CR29 publication-title: J R Stat Soc Ser B (Methodol) doi: 10.1111/j.2517-6161.1995.tb02031.x – volume: 83 start-page: 1241 year: 2002 ident: 1727_CR7 publication-title: J Neurochem doi: 10.1046/j.1471-4159.2002.01263.x – volume: 22 start-page: 7164 year: 2021 ident: 1727_CR19 publication-title: Int J Mol Sci doi: 10.3390/ijms22137164 – volume: 102 start-page: 15545 year: 2005 ident: 1727_CR31 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0506580102 – volume: 22 start-page: 1313 year: 2017 ident: 1727_CR12 publication-title: Mol Psychiatry doi: 10.1038/mp.2016.75 – volume: 390 start-page: 1260 year: 2017 ident: 1727_CR1 publication-title: Lancet doi: 10.1016/S0140-6736(17)32130-X |
SSID | ssj0001520 |
Score | 2.433366 |
Snippet | Schizophrenia (SCZ) is a complex neuropsychiatric disorder associated with altered bioenergetic pathways and mitochondrial dysfunction. Antipsychotic... |
SourceID | proquest gale pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1125 |
SubjectTerms | Allosteric properties Analysis Antipsychotic drugs Antipsychotics Aripiprazole Bioenergetics Clozapine Drug metabolism Drugs Energy metabolism Enzymatic activity Gas chromatography Gene expression Genes Glycolysis Health aspects Mass spectrometry Mass spectroscopy Medicine Medicine & Public Health Mental disorders Metabolism Metabolites Metabolomics Mitochondria Nervous system diseases Neurosciences Original Paper Oxidative phosphorylation Phosphorylation Post-transcription Post-translation Psychiatry Psychotropic drugs Risperidone Schizophrenia Therapeutic applications Tricarboxylic acid cycle |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9wwDBelg7KXsY92y9aWDAZ7aAMXfyTx4zFWyqB72kHfjC0746DNjebu_5-UONmubIO9xh84kizJlvQzwAcfqiBMbApfY1Oo1rjCqBILqVt0vjVtiXzfcfO1ul6pL7f6NhWF9VO2-xSSHDT1XOzG8sYJs5z_Q1a3IMX7RPPZnaR4JZaz_iWLNNysGI5aSqlSqcyf59gzR4-V8m9W6VGYdLA-V8_hWXIb8-XI5xdwELuXcHSTAuOvQI4oxH2-aXOi1ToVV60xDw-77_S5y-NQ5Zffxy3x_W7d3x_D6urzt0_XRXoPoUClxLYQUqNX2mkkpdSWsgxBuap2Eb2XpcbofaO0Z1A_rdt6YYIvUTlZE81VkFGewGG36eIbyBmFLVYoRGyCqgJ6sWhJ7bnamzqi0xmUE1ksJrBwfrPizs4wxwMpLZHSDqS0IoOLecyPESrjn70_MrUt7yOaGV0qB6D1MSKVXbInWzG-VQanez1J_nG_eeKXTfuvt5IDjo02osrg_dzMIzmnrIubXW-FWZCvUxvdZPB65PO8bobhF01VZ3A5Mf7X5H__qbf_1_0dPCX5VWM-4Skcbh928Yx8nK0_H0T6J0_T7v0 priority: 102 providerName: Springer Nature |
Title | Effects of antipsychotic drugs on energy metabolism |
URI | https://link.springer.com/article/10.1007/s00406-023-01727-2 https://www.ncbi.nlm.nih.gov/pubmed/38072867 https://www.proquest.com/docview/3076085926 https://www.proquest.com/docview/2902937958 |
Volume | 274 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9QwDLdge-EFMfFVGFMnIfEAEdd8NM0TuqHbJhATQpx0PEWNk6KTtt5Y7_5_4jbXcZPYU6U0iVLbsd3Y_gXgrfOl5yZUzGmsmGxMzYwskAnVYO0a0xRI5x3fLsrzufyyUIt04NaltMqtTuwVtV8hnZF_FBRCqpTh5afrP4xujaLoarpC4yHsE3QZpXTpxfjDFS3dAMtoKH4phExFM33pHEkvpd9SNlG04YzvGKa76vkf-3QnYNrbodMn8Dg5kPl04PgBPAjtUxADCHGXr5o8kmqZaquWmPubze_Y3OahL_LLr8I6sv1y2V09g_np7Ofnc5auQ2AoJV8zLhQ6qWqFUSc1hSi8l3Wp64DOiUJhcK6SyhGmn1KNnhjvCpS10JHk0osgnsNeu2rDS8gJhC2UyHmovCw9Oj5potartTM6YK0yKLa0sJiwwunKiks7ohz39LORfrann-UZvB_HXA9IGff2fkcktrSN4sxYp2qAuD4CpLJTcmRLgrfK4HCnZxR_3H29ZZJN26-zt8KSwfH4mkZSSlkbVpvOcjOJro6OUpPBi4G547oJhZ9Xpc7gw5bbt5P__6Ne3b-W1_CIR5doSB88hL31zSa8iS7N2h31cnsE-9OzX19n8Xkyu_j-I7bO-fQvNYbzEg |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6V7QEuqIhXoECQQBzAYuNHEh8QKtBqS9sVQq3Um4kfQSu12bbZFeJP8RuZyatsJXrrNX7ImYdn7Jn5DPDK-tRzHXJmM5czWeqCaZk4JlTpClvqMnF033EwTSdH8uuxOl6DP30tDKVV9ntis1H7uaM78veCQki50jz9eHbO6NUoiq72T2i0YrEXfv_CI1v9YfcL8vc15zvbh58nrHtVgDkp-YJxoZyVqlAOVbtMROK9LNKsCM5akSgXrM2lsgSNp1SZjbW3iZOFyHDl0osgcN5bsC4FHmVGsP5pe_rt-7D3ozVsbnU0RUyFkF2ZTlOsR_pCCb-Uv4ReA-MrpvCqQfjHIl4J0TaWb2cD7nYua7zVytg9WAvVfRAt7HEdz8sYmTPrqrlmLvYXy5_4uYpDU1YYn4YFCtrJrD59AEc3QqqHMKrmVXgMMcG-hdRxHnIvU-8sH5e4zxaZ1VlwhYog6WlhXIdOTo9knJgBV7mhn0H6mYZ-hkfwdhhz1mJzXNv7DZHYkOLizK7o6g9wfQSBZbbIdU4JUCuCzZWeqHButblnkukUvjaX4hnBy6GZRlISWxXmy9pwPUbnKtMqj-BRy9xh3YT7z_M0i-Bdz-3Lyf__U0-uX8sLuD05PNg3-7vTvadwh6ND1iYvbsJocbEMz9ChWtjnnRTH8OOmFecvo0MvDw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIiEuCMQrUCBIIA4QdeNHHB8QqiirlkLFgUp7M_GrWqnNlmZXiL_Gr2Mmr7KV6K3XOLbseXjG9sw3AK-sLzzTocyscmUmoq4yLXKXcRldZaOOuaP7jq-Hxd6R-DyTsw34M-TCUFjlsCe2G7VfOLoj3-b0hFRKzYrt2IdFfNudfjj7mVEFKXppHcppdCJyEH7_wuNb835_F3n9mrHpp-8f97K-wkDmhGDLjHHprJCVdKjmMee596IqVBWctTyXLlhbCmkJJk_KqCba29yJiitchfA8cBz3BtxUXOakY2o2HvbQynaQkJreTjkXfcJOm7ZHmkOhvxTJhP5DxtaM4mXT8I9tvPRY29rA6V240zuv6U4nbfdgI9T3gXcAyE26iCmyad7ndc1d6s9Xx_i5TkObYJiehiWK3Mm8OX0AR9dCqIewWS_q8BhSAoALhWMslF4U3lk2ibjjVspqFVwlE8gHWhjX45RTuYwTMyIst_QzSD_T0s-wBN6Ofc46lI4r_35DJDakwjiyq_pMBJwfgWGZHXKiC4LWSmBr7U9UPbfePDDJ9KrfmAtBTeDl2Ew9KZytDotVY5ieoJultCwTeNQxd5w3VQBgZaESeDdw-2Lw_y_qydVzeQG3UF3Ml_3Dg6dwm6Fn1kUxbsHm8nwVnqFntbTPWxFO4cd168xfp_sx3w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+antipsychotic+drugs+on+energy+metabolism&rft.jtitle=European+archives+of+psychiatry+and+clinical+neuroscience&rft.au=Panizzutti%2C+Bruna&rft.au=Bortolasci%2C+Chiara+C&rft.au=Spolding%2C+Briana&rft.au=Kidnapillai%2C+Srisaiyini&rft.date=2024-08-01&rft.issn=1433-8491&rft.eissn=1433-8491&rft.volume=274&rft.issue=5&rft.spage=1125&rft_id=info:doi/10.1007%2Fs00406-023-01727-2&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0940-1334&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0940-1334&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0940-1334&client=summon |